SLDB
Solid Biosciences LLC
NASDAQ: SLDB · HEALTHCARE · BIOTECHNOLOGY
$7.26
+2.98% today
Updated 2026-04-30
Market cap
$733.18M
P/E ratio
—
P/S ratio
3.65x
EPS (TTM)
$-1.99
Dividend yield
—
52W range
$2 – $9
Volume
1.3M
Solid Biosciences LLC (SLDB) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $55.70M | $40.64M | $76.19M | $139.60M | $103.47M | $171.17M | $232.38M | $260.25M | $164.94M | $188.66M |
| Cash & equivalents | $28.59M | $7.68M | $52.08M | $86.37M | $76.04M | $154.74M | $119.14M | $155.38M | $74.02M | $80.23M |
| Current assets | $55.70M | $39.97M | $70.66M | $128.64M | $86.30M | $158.90M | $222.61M | $219.64M | $129.73M | $157.30M |
| Total liabilities | $75.62M | $78.52M | $135.45M | $14.41M | $23.42M | $39.08M | $24.17M | $48.59M | $38.46M | $51.42M |
| Current liabilities | $13.92M | $6.87M | $11.27M | $12.48M | $18.28M | $24.48M | $23.60M | $22.51M | $14.52M | $30.26M |
| Long-term debt | — | — | — | — | — | — | — | — | — | — |
| Shareholder equity | $-67.51M | $-84.36M | $-59.26M | $125.18M | $80.05M | $132.09M | $208.21M | $211.67M | $126.48M | $137.25M |
| Retained earnings | $-67.71M | $-84.94M | $-124.26M | $-199.06M | $-316.28M | $-404.57M | $-476.76M | $-562.74M | $-658.75M | $-783.45M |
| Accounts receivable | — | — | — | — | — | $0.00 | $110000.00 | $0.00 | — | — |
| Inventory | — | — | — | — | — | — | $6.01M | — | — | — |
| Goodwill | — | — | — | — | — | — | — | — | — | — |